4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-10-000043
Chairman/CEO/President bought 75,833 shares at $0.05 ($3,792)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · Chairman/CEO/President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2010-10-21 | Purchase : show line 1 in the form | +43,333 | $0.05 | $2,167 | 1,172,986 | D |
| 2010-10-21 | Purchase : show line 2 in the form | +32,500 | $0.05 | $1,625 | 2,468,521 | I |
| Open-market purchases · 75,833 sh · avg $0.05 · $3,792 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2010-10-21 | Returned to the company : show line 3 in the form Convertible Debt | −43,333 | $0.05 | $2,167 | $0.05 | 2010-10-27 | 43,333 | 0 | D |
| 2010-10-21 | Returned to the company : show line 4 in the form Convertible Debt | −32,500 | $0.05 | $1,625 | $0.05 | 2010-10-27 | 32,500 | 0 | I |
Loading xslF345X03/primary_doc.xml…